What is the appropriate work‑up and treatment for bilateral basal ground‑glass opacities on chest CT?

Bilateral Basal Ground-Glass Opacities: Work-Up and Treatment

The appropriate work-up for bilateral basal ground-glass opacities requires systematic exclusion of infection first, followed by consideration of drug-related pneumonitis, organizing pneumonia, or interstitial lung disease, with bronchoscopy and BAL indicated when empiric antibiotics fail to produce improvement within 48-72 hours. 1, 2

Initial Clinical Assessment

Key Historical Elements to Obtain

• Temporal relationship to new medications or immunosuppressive therapy, particularly molecular targeted agents, immune checkpoint inhibitors, or chronic corticosteroids, as drug-related pneumonitis (DRP) commonly presents with bilateral ground-glass opacities 1

• Symptom onset and duration: Acute onset (<2 weeks) suggests infection or acute interstitial pneumonia; subacute (weeks to 3 months) points toward cryptogenic organizing pneumonia (COP), hypersensitivity pneumonitis (HP), or atypical infections; chronic course (>3 months) indicates possible mycobacterial infection or fibrotic disease 2

• Exposure history for hypersensitivity pneumonitis: Detailed occupational and environmental exposures are essential, as HP can present with bilateral ground-glass opacities and centrilobular nodules 2

• Immunosuppression status: Patients on chronic immunosuppression are at high risk for Pneumocystis jirovecii pneumonia (PCP), which characteristically presents with bilateral ground-glass opacities 1, 3

• COVID-19 exposure or recent infection, as post-COVID residual abnormalities can manifest as persistent ground-glass opacities 4

Diagnostic Work-Up Algorithm

Step 1: Exclude Infection (First 48-72 Hours)

• Initiate empiric broad-spectrum antibiotics covering typical and atypical organisms 2

• Obtain microbiologic studies: Sputum cultures, blood cultures, respiratory viral panel, and consider PCP testing if immunosuppressed 1, 3

• Assess clinical response at 48-72 hours: Lack of improvement strongly indicates non-infectious inflammatory process and should prompt immediate escalation 2

Step 2: Bronchoscopy with BAL (If No Response to Antibiotics)

• Bronchoscopy is recommended when antibiotics fail within 48-72 hours or when HRCT suggests inflammatory pattern rather than consolidative pneumonia 1, 2

• BAL fluid analysis should include:

  • Infectious organism cultures (bacterial, fungal, mycobacterial, PCP) 1
  • Cell count and differential: Elevated lymphocytes suggest HP or organizing pneumonia; elevated eosinophils indicate eosinophilic pneumonia; elevated neutrophils may suggest DRP or infection 1
  • Cytology to exclude malignancy or diffuse alveolar hemorrhage 1

• Transbronchial biopsy can confirm organizing pneumonia and exclude alternative diagnoses, with favorable risk-benefit profile 2

Step 3: High-Resolution CT Pattern Recognition

• Drug-related pneumonitis: Bilateral nonsegmental ground-glass opacities with temporal association to drug initiation; may be transient and asymptomatic 1

• Cryptogenic organizing pneumonia (COP): Patchy consolidation in subpleural or peribronchial distribution that may migrate over time; peripheral distribution similar to chronic eosinophilic pneumonia 5, 2

• Hypersensitivity pneumonitis: Centrilobular nodules with "three-density sign" (mosaic attenuation, ground-glass opacity, air-trapping); upper/middle lobe predominance 2

• Desquamative interstitial pneumonia (DIP): Diffuse ground-glass opacity in middle and lower lung zones, typically in cigarette smokers 5

• Post-COVID residual abnormalities: Use Fleischner Society terminology; avoid term "fibrosis" unless traction bronchiectasis, honeycombing, or architectural distortion with volume loss are present 4

Treatment Recommendations

For Drug-Related Pneumonitis

• Discontinue the offending agent immediately if DRP is suspected based on temporal relationship and exclusion of infection 1

• Corticosteroids are indicated for symptomatic DRP: Typical regimen is oral prednisone 0.5-1 mg/kg/day with gradual taper over weeks to months 1

• Monitor for improvement: Clinical and radiographic improvement should occur within days to weeks; lack of response warrants reconsideration of diagnosis 1

For Cryptogenic Organizing Pneumonia

• Corticosteroids are the cornerstone of therapy: Oral prednisolone typically yields rapid clinical and radiological improvement within days to weeks 5, 2

• Response rate exceeds 80%, but relapse is common and may require prolonged tapering over 6-12 months 5, 2

• Prognosis is excellent with appropriate corticosteroid therapy 2

For Hypersensitivity Pneumonitis

• Antigen avoidance is essential and must be combined with corticosteroids for optimal outcomes 2

• Corticosteroids improve symptoms and imaging when combined with exposure elimination 2

• Prognosis is generally favorable when inciting antigen is removed and steroids administered 2

For Desquamative Interstitial Pneumonia

• Smoking cessation is mandatory as DIP occurs almost exclusively in smokers 5

• Corticosteroids are effective: Overall survival is approximately 70% at 10 years, significantly better than usual interstitial pneumonia 5

Critical Pitfalls to Avoid

• Do not continue empiric antibiotics beyond 48-72 hours without clinical improvement, as this delays appropriate work-up and corticosteroid initiation 2

• Never initiate anti-tuberculosis therapy based solely on radiographic opacities, as this causes unnecessary drug toxicity and delays correct diagnosis 2

• Do not overlook detailed exposure history, which is essential for diagnosing HP and improving diagnostic accuracy 2

• Avoid using the term "interstitial lung abnormality" (ILA) for post-COVID changes, as ILA should only be used for incidental or unexpected findings per Fleischner guidelines 4

• Do not assume all ground-glass opacities are COVID-19, even during pandemic conditions; PCP and other differential diagnoses must be considered, particularly in immunosuppressed patients 3

• Avoid rechallenge with suspected offending drugs, as this can worsen DRP and is often impractical in clinical settings 1

Prognosis by Etiology

• Cryptogenic organizing pneumonia: >80% response rate to corticosteroids with excellent prognosis 2

• Hypersensitivity pneumonitis: Generally favorable when antigen removed and steroids administered 2

• Drug-related pneumonitis: Variable depending on severity; most improve with drug cessation and corticosteroids 1

• Desquamative interstitial pneumonia: 70% survival at 10 years with smoking cessation and treatment 5

• Acute interstitial pneumonia: High mortality risk (≥50%) if this pattern is present 2